Science in Images: ISMRM, Honolulu Hawaii

This years ISMRM meeting in Honolulu, Hawaii has been a roaring success for the MSU MCIL team.

With 4 oral presentations, a study group presentation and award, as well as an award for scientific merit, the MSU Radiology department has demonstrated that their research has value on a global scale.

Dr Barbara Blanco Fernández, awarded 1st place in the Molecular and Cellular imaging study group.

The Molecular and Cellular imaging group, a focus group of the ISMRM community, aims to provide an informal atmosphere to discuss the progress, evaluation, and application of molecular and cellular imaging using Magnetic resonance technology.

One highlight of the group is its championing of the exceptional research being performed by it’s junior members. Having delivered both a high impact abstract, as well as an oral presentation as part of the general meeting, Dr Blanco Fernández was selected to present her work on nanoparticles for immunology at the group chapter meeting, being awarded the top prize for research excellence.

The highly competitive and prestigious award was for Barbara’s research highlighting the use of Chitin and Chitin-materials for vaccines and nanocarriers for immunotherapy.

The group also received recognition for its outstanding research in the form of multiple accepted presentations.

Dr Christiane Mallett, presented a poster on her work on using MRI to measure acetaminophen toxicity in the liver.

Prof Erik M Shapiro presented a talk on behalf of Jamal Afridi on his PhD work, investigating Machine learning for intelligent detection of cellular transplants using MRI.

Dr Dorela Shuboni-Mulligan gave presentation on her groundbreaking work, investigating the link between diabetes and dysregulation of OATP transporters.

The final oral presentation and award was presented to myself, for the use of Polymer and Peptides as Theranostic agents. Peptides have been my area of specialty since undergraduate, so getting to apply my knowledge to molecular imaging and cancer therapy was a rewarding challenge for me.

I presented my work on switchable MRI imaging agent, capable of the non-invasive detection of specific cell types for cellular transplants, cancer detection and therapeutic delivery.

The ISMRM recognizes research excellence by awarding high-impact abstracts. Having scored in the top 5% of all submitted abstracts, I was awarded the Summa cum Laude IRMRM merit award.







Can I get a round of applause for the achievent of all these awesome #WomeninSTEM?